We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Head and neck surgery during the coronavirus‐19 pandemic: The University of California San Francisco experience.
- Authors
Wai, Katherine C.; Xu, Mary Jue; Lee, Rex H.; El‐Sayed, Ivan H.; George, Jonathan R.; Heaton, Chase M.; Knott, P. Daniel; Park, Andrea M.; Ryan, William R.; Seth, Rahul; Ha, Patrick K.
- Abstract
Background: Guidelines regarding head and neck surgical care have evolved during the coronavirus‐19 (COVID‐19) pandemic. Data on operative management have been limited. Methods: We compared two cohorts of patients undergoing head and neck or reconstructive surgery between March 16, 2019 and April 16, 2019 (pre‐COVID‐19) and March 16, 2020 and April 16, 2020 (COVID‐19) at an academic center. Perioperative, intraoperative, and postoperative outcomes were recorded. Results: There were 63 operations during COVID‐19 and 84 operations during pre‐COVID‐19. During COVID‐19, a smaller proportion of patients had benign pathology (12% vs 20%, respectively) and underwent thyroid procedures (2% vs 23%) while a greater proportion of patients underwent microvascular reconstruction±ablation (24% vs 12%,). Operative times increased, especially among patients undergoing microvascular reconstruction±ablation (687 ± 112 vs 596 ± 91 minutes, P =.04). Complication rates and length of stay were similar. Conclusions: During COVID‐19, perioperative outcomes were similar, operative time increased, and there were no recorded transmissions to staff or patients. Continued surgical management of head and neck cancer patients can be provided safely.
- Subjects
SAN Francisco (Calif.); UNIVERSITY of California, San Francisco; PANDEMICS; COVID-19; NECK; HEAD &; neck cancer; PLASTIC surgery; THYROIDECTOMY
- Publication
Head & Neck, 2021, Vol 43, Issue 2, p622
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.26514